scholarly journals Erratum to: Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet

2017 ◽  
Vol 53 (4) ◽  
pp. 578-578 ◽  
Author(s):  
Nicola Imperatore ◽  
Raffaella Tortora ◽  
Anna Testa ◽  
Nicolò Gerbino ◽  
Nicola Caporaso ◽  
...  
2017 ◽  
Vol 53 (4) ◽  
pp. 507-516 ◽  
Author(s):  
Nicola Imperatore ◽  
Raffaella Tortora ◽  
Anna Testa ◽  
Nicolò Gerbino ◽  
Nicola Caporaso ◽  
...  

2015 ◽  
Vol 41 (4) ◽  
pp. 352-359 ◽  
Author(s):  
R. Tortora ◽  
P. Capone ◽  
G. De Stefano ◽  
N. Imperatore ◽  
N. Gerbino ◽  
...  

2015 ◽  
Vol 41 (8) ◽  
pp. 795-796
Author(s):  
G. Chiarioni ◽  
S. De Marchi ◽  
M. Prior ◽  
E. Arosio

2014 ◽  
Vol 46 ◽  
pp. S57
Author(s):  
R. Tortora ◽  
G. De Stefano ◽  
N. Imperatore ◽  
P. Capone ◽  
S. Tafuto ◽  
...  

Author(s):  
Lorcan McGrogan ◽  
Mary Mackinder ◽  
Fiona Stefanowicz ◽  
Maria Aroutiounova ◽  
Anthony Catchpole ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 947
Author(s):  
Anna Szaflarska-Popławska

Potential celiac disease (PCD) is a heterogeneous disease; only some patients develop full celiac disease (CD), characterised by advanced atrophic changes in the small intestine. Few accurate prognostic factors exist for the progression of PCD; therefore, therapeutic decisions should be made on an individual basis in each case. Patients with clinical gastroenterological or parenteral symptoms often benefit from a gluten-free diet, and those left on a diet containing gluten should receive clinical, serological and histopathological supervision.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Emilia Majsiak ◽  
Magdalena Choina ◽  
Dominik Golicki ◽  
Alastair M. Gray ◽  
Bożena Cukrowska

Abstract Background Coeliac disease (CD) is characterised by diverse clinical symptoms, which may cause diagnostic problems and reduce the patients’ quality of life. A study conducted in the United Kingdom (UK) revealed that the mean time between the onset of coeliac symptoms and being diagnosed was above 13 years. This study aimed to analyse the diagnostic process of CD in Poland and evaluate the quality of life of patients before and after CD diagnosis. In addition, results were compared to the results of the original study conducted in the UK. Methods The study included 2500 members of the Polish Coeliac Society. The patients were asked to complete a questionnaire containing questions on socio-demographic factors, clinical aspects and quality of life, using the EQ-5D questionnaire. Questionnaires received from 796 respondents were included in the final analysis. Results The most common symptoms reported by respondents were bloating (75%), abdominal pain (72%), chronic fatigue (63%) and anaemia (58%). Anaemia was the most persistent symptom, with mean duration prior to CD diagnosis of 9.2 years, whereas diarrhoea was observed for the shortest period (4.7 years). The mean duration of any symptom before CD diagnosis was 7.3 years, compared to 13.2 years in the UK. CD diagnosis and the introduction of a gluten-free diet substantially improved the quality of life in each of the five EQ-5D-5L health dimensions: pain and discomfort, anxiety and depression, usual activities, self-care and mobility (p < 0.001), the EQ-Index by 0.149 (SD 0.23) and the EQ-VAS by 30.4 (SD 28.3) points. Conclusions Duration of symptoms prior to the diagnosis of CD in Poland, although shorter than in the UK, was long with an average of 7.3 years from first CD symptoms. Faster CD diagnosis after the onset of symptoms in Polish respondents may be related to a higher percentage of children in the Polish sample. Introduction of a gluten-free diet improves coeliac patients’ quality of life. These results suggest that doctors should be made more aware of CD and its symptoms across all age groups.


Sign in / Sign up

Export Citation Format

Share Document